Do no less than believe in your success. Belief and confidence set the tide level for background efficacy and everything we ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The following is a summary of “Randomized Controlled Trial of the Effects of High-Dose Ondansetron on Clinical Symptoms and Brain Connectivity in Obsessive-Compulsive and Tic Disorders,” published in ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...

A new study has found that prescribing blood thinners to adults under 65 with atrial fibrillation (AFib) but no other health risks does not help prevent stroke, mini-stroke (TIA), or memory problems.

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The US Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.

Researchers found that mindfulness meditation can modify how a person experiences pain in a way that uses no drugs, proving ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers.